We aimed to investigate the possible bond between CSF levels of DAT and regional brain metabolism studied with 18F-FDG positron emission tomography/computed tomography (PET/CT) in a population of patients with AD, in order to deepen the knowledge on the role of dopaminergic degeneration in the pathogenesis of the disease. This evidence concerns the gene SLC6A3 and Alzheimer disease.